Michael A. /. Davis - Oct 3, 2024 Form 4 Insider Report for CYANOTECH CORP (CYAN)

Signature
/s/Laura L. Taylor, by Power of Attorney
Stock symbol
CYAN
Transactions as of
Oct 3, 2024
Transactions value $
$13,800
Form type
4
Date filed
10/3/2024, 03:27 PM
Previous filing
Oct 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYAN Cyanotech Corporation Common Stock Purchase $3.8K +5K +0.34% $0.76 1.47M Oct 1, 2024 By self as trustee of the Michael Arlen Davis Revocable Trust F1
transaction CYAN Cyanotech Corporation Common Stock Award $10K +13.2K +0.9% $0.76 1.48M Oct 1, 2024 By self as trustee of the Michael Arlen Davis Revocable Trust F2
holding CYAN Cyanotech Corporation Common Stock 12.1K Oct 3, 2024 Direct
holding CYAN Cyanotech Corporation Common Stock 31.3K Oct 3, 2024 By Spouse
holding CYAN Cyanotech Corporation Common Stock 150K Oct 3, 2024 By self as co-trustee for the Nyracai Davis Irr. Trust and the Nettizanne J. Davis Irr. Trust
holding CYAN Cyanotech Corporation Common Stock 58K Oct 3, 2024 By self as trustee for Nettizanne Johnstone Davis GST Exempt Trust
holding CYAN Cyanotech Corporation Common Stock 58.8K Oct 3, 2024 By self as trustee for Nyracai Johnstone Davis GST Exempt Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Adoption date of referenced 10b5-1(c) plan is: 03-06-2024
F2 To reduce the Company's ongoing cash expense, the Nominating and Corporate Governance Committee of the Board of Directors adopted a resolution allowing each director to elect to receive his quarterly director fees in the form of restricted stock in lieu of cash. The Reporting Person elected to receive shares of restricted stock in lieu of cash for the second quarter of fiscal 2025.